Safety and efficacy profile of oral cyclosporine versus oral methotrexate versus oral acitretin in palmoplantar psoriasis and psoriasis vulgaris â?? A hospital based prospective investigator blind randomized controlled comparative study.

Krishna Institute of Medical Sciences Deemed University0 个研究点目标入组 120 人开始时间: 待定最近更新: 2021年11月24日

试验速览

暂无简介。

•A.Have given written consent before any treatment commenced.
•B.Be diagnosed to be suffering exclusively from Palmo-plantar psoriasis either by clinical examination or histopathology if required will be included in palmoplantar psoriasis group.
•C.Be diagnosed to be suffering from psoriasis vulgaris having more than 20% body surface area will be included in psoriasis vulgaris group.
•D.Have completed 18 years of age.
•E.Have to stop any other modality of treatment, two months prior to the inclusion in study.
•F.Be able and willing, in the view of investigator, to comply all study procedure.

•A.Patient with hypersensitivity to drug or patient intolerant to the study medication.
•B.Pregnant and lactating patient.
•C.Patient with Unrealistic expectations.
•D.Not willing for regular follow up.
•E.Patient with clinically significant cardiovascular, haematological, pancreatic, metabolic neurological or any other laboratory anomaly, which in the judgement of investigator, would interfere in participation in study or proper evaluation.
•F.Patient on any other systemic drugs therapy which in the judgement of investigator may interfere with interpretation of results.
•G.Patient having history of tuberculosis or chest X-ray showing evidence of any infective pathology.

发起方

Krishna Institute of Medical Sciences Deemed University